Mobile

A LONG-TERM FOLLOW UP STUDY TO EVALUATE THE SAFETY AND EFFICACY IN TRANSPLANT RECIPIENTS TREATED WITH MODIFIED RELEASE TACROLIMUS, FK506E (MR4); BASED IMMUNOSUPPRESSION REGIMEN

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-005714-20

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The objective of this study is to assess the safety and efficacy of FK506E (MR4) as long-term treatment in transplant recipients who have participated in one of the phase II PK or phase III studies on FK506E (MR4) and have received at least one dose of study medication.

Critère d'inclusion

  • Transplant Recipients

Liens